biotech · Recurrent Plasma Cell Myeloma · Anal Cancer Metastatic · ONCY
Oncolytics Biotech
ONCOLYTICS BIOTECH INC
Oncolytics Biotech is a biotech organization headquartered in San Diego, USA. It trades on NYSE under ticker ONCY. Primary therapeutic focus areas include Recurrent Plasma Cell Myeloma, Anal Cancer Metastatic, Ras-mutate
4350 Executive Dr, 325, San Diego, California 92121, US HQ
1998 Founded
46 Employees
Public company Type
ONCY · NYSE Ticker
Company details
- Status
- Public
- HQ
- 4350 Executive Dr, 325, San Diego, California 92121, US
- Founded
- 1998
- Employees
- 46
- Programs
- 23
- Drugs
- 14
- Patents
- 66
REO 029
Phase 2 · small molecule · Patients with advanced or metastatic gastrointestinal (GI) tumors.
REO 029 for Patients with advanced or metastatic gastrointestinal (GI) tumors. is a Phase 2 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Internal code REO 029
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ONCOLYTICS BIOTECH INC
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Patients with advanced or metastatic gastrointestinal (GI) tumors.
- Status
- active
- Trials
- 1